BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31041299)

  • 21. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
    Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
    [No Abstract]   [Full Text] [Related]  

  • 23. Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature.
    Wang X; Gong Z; Li SX; Yan W; Song Y
    BMC Urol; 2017 Sep; 17(1):77. PubMed ID: 28874193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
    Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
    J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of Epstein-Barr virus DNA in NK/T-cell lymphoma: a meta-analysis.
    Fei Q; Tian XK; Wu J; Zhu HM; Wang Y; Peng FY; Zhang WJ; Yin L; He X
    Onco Targets Ther; 2018; 11():997-1004. PubMed ID: 29520150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
    Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
    Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
    Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S
    Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology.
    Jaffe ES; Chan JK; Su IJ; Frizzera G; Mori S; Feller AC; Ho FC
    Am J Surg Pathol; 1996 Jan; 20(1):103-11. PubMed ID: 8540601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Huang WT; Chang KC; Huang GC; Hsiao JR; Chen HH; Chuang SS; Chen TY; Su WC; Tsao CJ
    Haematologica; 2005 Aug; 90(8):1063-9. PubMed ID: 16079105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature.
    Stadlmann S; Fend F; Moser P; Obrist P; Greil R; Dirnhofer S
    Hum Pathol; 2001 Nov; 32(11):1264-8. PubMed ID: 11727268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extranodal natural killer/T-cell lymphoma, nasal-type.
    Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
    Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.
    Gualco G; Domeny-Duarte P; Chioato L; Barber G; Natkunam Y; Bacchi CE
    Am J Surg Pathol; 2011 Aug; 35(8):1195-203. PubMed ID: 21716086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of cytotoxic T-cell and natural killer cell lymphomas.
    Jaffe ES; Krenacs L; Raffeld M
    Semin Hematol; 2003 Jul; 40(3):175-84. PubMed ID: 12876666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Epstein-Barr virus-positive cytotoxic T cell lymphoid hyperplasia in the upper aerodigestive tract, mimicking extranodal natural killer/T cell lymphoma, nasal type.
    Jianlan X; Yuhua H; Yuanyuan Z; Yanlin Z; Ping W; Wei L; Xiaoge Z; Mulan J
    Virchows Arch; 2019 Feb; 474(2):219-226. PubMed ID: 30488123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus.
    Zhao Q; Fan S; Chang Y; Liu X; Li W; Ma Q; Li Y; Wang Y; Zhang L; Zhang M
    Cancer Manag Res; 2019; 11():3555-3564. PubMed ID: 31118779
    [No Abstract]   [Full Text] [Related]  

  • 40. The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.
    Gru AA; Haverkos BH; Freud AG; Hastings J; Nowacki NB; Barrionuevo C; Vigil CE; Rochford R; Natkunam Y; Baiocchi RA; Porcu P
    Curr Hematol Malig Rep; 2015 Dec; 10(4):456-67. PubMed ID: 26449716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.